167 related articles for article (PubMed ID: 37180649)
1. Characteristics and survival analysis of breast cancer survivors with metachronous double primary cancers: a retrospective cohort study.
Song Y; Wang J; Wang X; Li R; Niu X; Yang Y; Yang X; Yin L; Wang Y; Zhang H; Shui R; Zhang C; An J
Transl Cancer Res; 2023 Apr; 12(4):939-948. PubMed ID: 37180649
[TBL] [Abstract][Full Text] [Related]
2. Characteristics and survival of patients with metachronous or synchronous double primary malignancies: breast and thyroid cancer.
Zhang L; Wu Y; Liu F; Fu L; Tong Z
Oncotarget; 2016 Aug; 7(32):52450-52459. PubMed ID: 27223440
[TBL] [Abstract][Full Text] [Related]
3. [Clinical characteristics and prognostic analysis of double primary breast cancer and thyroid cancer].
Zhai J; Kong XY; Fang Y; Wang J
Zhonghua Zhong Liu Za Zhi; 2021 Dec; 43(12):1287-1291. PubMed ID: 34915638
[No Abstract] [Full Text] [Related]
4. Breast cancer prognosis is better in patients who develop subsequent metachronous thyroid cancer.
Lei K; He X; Yu L; Ni C; Chen H; Guan D; Sun K; Zou H
PLoS One; 2019; 14(5):e0215948. PubMed ID: 31042767
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathological features, survival and risk in breast cancer survivors with thyroid cancer: an analysis of the SEER database.
Li S; Yang J; Shen Y; Zhao X; Zhang L; Wang B; Li P; Wang Y; Yi M; Yang J
BMC Public Health; 2019 Nov; 19(1):1592. PubMed ID: 31783815
[TBL] [Abstract][Full Text] [Related]
6. Metachronous double primary cancer after treatment of breast cancer.
Kim JY; Song HS
Cancer Res Treat; 2015 Jan; 47(1):64-71. PubMed ID: 25544582
[TBL] [Abstract][Full Text] [Related]
7. Relationship between metastasis and second primary cancers in women with breast cancer.
Li C; Liu M; Li J; Zhao X; Wang Y; Chen X; Wang W; Sun S; Feng C; Cai Y; Wu F; Du C; Zhang Y; Zhang S; Qu J
Front Oncol; 2022; 12():942320. PubMed ID: 36248962
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathologic features of breast cancers diagnosed in women treated with prior radiation therapy for Hodgkin lymphoma: Results from a population-based cohort.
Wong SM; Ajjamada L; Weiss AC; Prakash I; Skamene S; Boileau JF; Pollak MN; Basik M
Cancer; 2022 Apr; 128(7):1365-1372. PubMed ID: 34919263
[TBL] [Abstract][Full Text] [Related]
9. Clinical and sociodemographic risk factors associated with the development of second primary cancers among postmenopausal breast cancer survivors.
Bailey S; Ezratty C; Mhango G; Lin JJ
Breast Cancer; 2023 Mar; 30(2):215-225. PubMed ID: 36316601
[TBL] [Abstract][Full Text] [Related]
10. A Nomogram for Predicting Liver Metastasis of Lymph-Node Positive Luminal B HER2 Negative Subtype Breast Cancer by Analyzing the Clinicopathological Characteristics of Patients with Breast Cancer.
Yue Y; Liang J; Wu Y; Tong W; Li D; Cao X; Wang X
Technol Cancer Res Treat; 2022; 21():15330338221132669. PubMed ID: 36254567
[No Abstract] [Full Text] [Related]
11. High incidence combination of multiple primary malignant tumors of the digestive system.
Yang XB; Zhang LH; Xue JN; Wang YC; Yang X; Zhang N; Liu D; Wang YY; Xun ZY; Li YR; Sun HS; Zhao LJ; Zhao HT
World J Gastroenterol; 2022 Nov; 28(41):5982-5992. PubMed ID: 36405110
[TBL] [Abstract][Full Text] [Related]
12. A Single-Center Retrospective Study of Patients with Double Primary Cancers: Breast Cancer and EGFR-Mutant Non-Small Cell Lung Cancer.
Moran T; Quiroga V; Cirauqui B; Vila L; Gil-Moreno M; Carcereny E; Margeli M; Muñoz-Marmol A; Mate JL; Velarde JM; Molina MA; Rosell R
Oncol Res Treat; 2019; 42(3):107-114. PubMed ID: 30799393
[TBL] [Abstract][Full Text] [Related]
13. Second Primary Tumors associated with Breast Cancer: Kuwait Cancer Control Center Experience.
Fayaz S; Demian GA; Eissa HE; Abuzalouf S
Gulf J Oncolog; 2017 Sep; 1(25):35-40. PubMed ID: 29019328
[TBL] [Abstract][Full Text] [Related]
14. Time Intervals between Double Primary Breast and Ovarian Cancers and Survival Outcomes of Patients with Both Cancers: A SEER Database Analysis.
He XQ; Gao YT; Zhang X; Jiang H
Biomed Res Int; 2022; 2022():4557346. PubMed ID: 35707375
[TBL] [Abstract][Full Text] [Related]
15. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
[TBL] [Abstract][Full Text] [Related]
16. Characteristics of Patients With Second Primary Lung Cancer Following Breast Cancer: A Retrospective Descriptive Study.
Wang KY; Lee CS; Vempati P; Sharma R; Kohn N; Seetharamu N
Clin Lung Cancer; 2023 Sep; 24(6):e198-e204. PubMed ID: 37268494
[TBL] [Abstract][Full Text] [Related]
17. The co-occurrence of both breast- and differentiated thyroid cancer: incidence, association and clinical implications for daily practice.
Piek MW; de Boer JP; van Duijnhoven F; van der Wal JE; Vriens M; van Leeuwaarde RS; van der Ploeg IMC
BMC Cancer; 2022 Sep; 22(1):1018. PubMed ID: 36163009
[TBL] [Abstract][Full Text] [Related]
18. Prognosis of Pancreatic Cancer Patients with Synchronous or Metachronous Malignancies from Other Organs Is Better than Those with Pancreatic Cancer Only.
Shin SJ; Park H; Sung YN; Yoo C; Hwang DW; Park JH; Kim KP; Lee SS; Ryoo BY; Seo DW; Kim SC; Hong SM
Cancer Res Treat; 2018 Oct; 50(4):1175-1185. PubMed ID: 29268568
[TBL] [Abstract][Full Text] [Related]
19. Biological Characteristics and Long-term Outcomes in Node-negative Breast Cancer.
Agostinetto E; Giordano L; Torrisi R; De Sanctis R; Masci G; Losurdo A; Zuradelli M; Tinterri C; Gatzemeier W; Testori A; Alloisio M; De Rose F; Fernandes B; Santoro A
Clin Breast Cancer; 2020 Aug; 20(4):e481-e489. PubMed ID: 32279915
[TBL] [Abstract][Full Text] [Related]
20. Second Primary Lung Cancer After Breast Cancer: A Population-Based Study of 6,269 Women.
Wang R; Yin Z; Liu L; Gao W; Li W; Shu Y; Xu J
Front Oncol; 2018; 8():427. PubMed ID: 30356721
[No Abstract] [Full Text] [Related]
[Next] [New Search]
